A Randomised, Double-Blind, Double Dummy Trial To Compare The Efficacy And Safety Of ARIMIDEX (ZD1033 1MG Daily) With TAMOXIFEN (20MG Daily) As First Line Therapy For Advanced Breast Cancer In Postmenopausal Women.
Study identifier:1033IL/0027
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomised, Double-Blind, Double Dummy Trial To Compare The Efficacy And Safety Of ARIMIDEX (ZD1033 1MG Daily) With TAMOXIFEN (20MG Daily) As First Line Therapy For Advanced Breast Cancer In Postmenopausal Women.
Medical condition
Breast Cancer
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Aug 1995
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
